Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Long-Term Kinetics of Serological Antibodies againstInternational journal of environmental research and public health · 2022
   Pooled it
2. Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
   Trial
3. A narrative review of heterogeneity in SARS-CoV-2 infection outcomes and vaccine efficacy: strategizing pandemic preparedness in Africa.Frontiers in public health · 2026
   Review
4. Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.PLoS neglected tropical diseases · 2021
   Review
5. Inference of Naturally Acquired Immunity Using a Self-matched Negative-Control Design.Epidemiology (Cambridge, Mass.) · 2021
   Article
6. Protection From Natural Immunity Against Enteric Infections and Etiology-Specific Diarrhea in a Longitudinal Birth Cohort.The Journal of infectious diseases · 2020
   Article
7. Wading Into the Morass: Natural Immunity to Enteropathogens.The Journal of infectious diseases · 2020
   Article
8. Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.PloS one · 2018
   Article
9. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.Journal of immunological methods · 2015
   Article
10. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.Infection and immunity · 2015
    Article
11. Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.PLoS neglected tropical diseases · 2014
    Article
12. Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.Clinical and vaccine immunology : CVI · 2014
    Review
13. Antibody-mediated inhibition of ricin toxin retrograde transport.mBio · 2014
    Article
14. Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks.PLoS neglected tropical diseases · 2013
    Article

Corrections and comments

• Comment on
  Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.2012

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.